To use a drug tranexamic acid to reduce blood loss during femur and hip surgeries

Not Applicable

Completed

• Conditions: Health Condition 1: V99- Unspecified transport accident

• Registration Number: CTRI/2019/09/021302
• Lead Sponsor: Rajshree Mandhare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-11-12
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

1)All consecutive patients requiring open reduction surgeries from orthopedic ward

2)All patients giving informed consent

Exclusion Criteria

1)Patients unwilling for giving their consent

2)Patients aged <18 or >65year

3)Patients having hematological diseases (Thromboembolic

events, hemoglobinopathy, coagulopathy

4)Patients having renal failure.

5)Pregnant and lactating women, patients with underlying

co-morbid conditions

6)Patients having disturbances of colour vision

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the effect of tranexamic acid in decrease in blood loss <br/ ><br>perioperatively in patients undergoing open reduction surgeries of hip,femur or tibiaTimepoint: It will be assessed at the end of study

Secondary Outcome Measures

Name	Time	Method
To compare hemoglobin reduction in patients undergoing major orthopedic if tranexamic acid is used surgeries and requirement of blood transfusions.Timepoint: It will be assesed thoroughly at the end of the study.